Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $2.96 USD
Change Today +0.08 / 2.78%
Volume 1.8M
SQNM On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 07/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Allan T. Bombard M.D., M.B.A, Facog, Facs, Facmg

Former Chief Medical Officer, Sequenom Inc.
AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 2 different industries.

62$430,068
As of Fiscal Year 2014

Background*

Dr. Allan T. Bombard, M.D., FACOG, FACS, FACMG served as the Chief Medical Officer at Sequenom Inc. from January 2009 to June 10, 2014. Dr. Bombard oversaw Sequenom's clinical and medical affairs, including clinical strategy, operations and clinical advocacy. He served as Medical Director of DNA Direct, Inc. He is a Professor at the Albert Einstein College of Medicine and the State University of New York at Downstate Medical Center. From October 2008 to January 2009, ...

Read Full Background

Corporate Headquarters*

3595 John Hopkins Court
San Diego, California 92121

United States

Phone: 858-202-9000
Fax: 858-202-9001

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

MD
George Washington University
BA
Colgate University
MBA
University of San Diego

Other Affiliations*

Annual Compensation*

Salary$192,224
Total Annual Compensation$192,224

Stock Options*

Restricted Stock Awards$90,800
All Other Compensation$828
Exercised Options6,667
Exercised Options Value$25,348
Total Value of Options$25,348
Total Number of Options6,667

Total Compensation*

Total Annual Cash Compensation$193,052
Total Short Term Compensation$192,224
Other Long Term Compensation$91,628
Total Calculated Compensation$430,068
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SQNM:US $2.96 USD +0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Elazar Rabbani Ph.D.Co-Founder, Chairman, Chief Executive Officer and Secretary
Enzo Biochem Inc.
$555.5K
Nachum Shamir Chief Executive Officer and President
Luminex Corporation
$275.0K
Torben Jörgensen B.Sc.Chief Executive Officer and President
Biotage AB
kr4.0M
R. Bradley Gray Chief Executive Officer, President and Director
NanoString Technologies, Inc.
$441.8K
Michael W. Hunkapiller Ph.D.Executive Chairman, Chief Executive Officer and President
Pacific Biosciences of California, Inc.
$1.00
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SEQUENOM INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.